Access cutting-edge x-linked retinitis pigmentosa treatment through this clinical trial at a research site in Ann Arbor. Study-provided care at no cost to qualified participants.
Access x-linked retinitis pigmentosa specialists in Ann Arbor at no cost
This study follows strict safety protocols and ethical guidelines
All study-related x-linked retinitis pigmentosa treatment provided free
The purpose of this study is to assess the safety and tolerability of subretinal delivery of Adeno-associated Virus Vector (AAV5 hRKp.RPGR) gene therapy in adults and children with X-linked retinitis pigmentosa.
Sponsor: Janssen Research & Development, LLC
Check if you qualify for this x-linked retinitis pigmentosa clinical trial in Ann Arbor, MI
If you're searching for x-linked retinitis pigmentosa treatment options in Ann Arbor, MI, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Ann Arbor research site is actively enrolling participants for this clinical trial. You'll receive care from experienced x-linked retinitis pigmentosa specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.